Related Experiment Videos

[Studies on in vitro expression for gI gene of Marek's disease in E. coli by pGEX vector]

J Ding1, Z Cui

  • 1Veterinary Medical College, Yangzhou University, Yangzhou 225009, China.

Insights

Marek

Area of Science:

  • Veterinary Virology
  • Molecular Biology
  • Immunology

Background:

  • Marek's disease virus (MDV) causes significant economic losses in the poultry industry.
  • The glycoprotein I (gI) gene of MDV is a potential target for vaccine development.
  • Understanding the expression and antigenicity of MDV gI is crucial for developing effective control strategies.

Purpose of the Study:

  • To clone and express the Marek's disease virus glycoprotein I (gI) gene.
  • To optimize the expression conditions for the GST-gI fusion protein.
  • To evaluate the antigenicity of the expressed GST-gI fusion protein.

Main Methods:

  • Polymerase chain reaction (PCR) was used to amplify the MDV gI gene.
  • The amplified gI gene was cloned into the pGEX-6p-1 vector.
  • Recombinant bacteria expressing GST-gI fusion protein were cultured and induced with IPTG.
  • Protein expression was analyzed using SDS-PAGE and Western blotting.
  • Antigenicity was assessed by injecting the fusion protein into mice and performing indirect fluorescent assays (IFA).

Main Results:

  • The MDV gI gene was successfully amplified and cloned.
  • Optimal expression of GST-gI fusion protein was achieved with 0.2-0.5 mmol/L IPTG and specific induction times.
  • Temperature had minimal impact on protein expression.
  • The expressed GST-gI fusion protein demonstrated positive antigenicity in mice via IFA.

Conclusions:

  • The study successfully cloned and expressed the Marek's disease virus glycoprotein I gene as a GST-gI fusion protein.
  • Optimized expression conditions were established for the recombinant protein.
  • The results confirm the antigenicity of the MDV gI protein, supporting its potential as a vaccine candidate.

Related Concept Videos